Catalyst Event
Samsung Biologics Co Ltd (207940) · Other
From Akros K-Manufacturing 50 Index (AKMNF50)
3/20/2026, 12:00:00 AM
Announced a KRW 520 billion capital increase for its wholly-owned U.S. subsidiary on March 20, 2026, to finance the acquisition of the Rockville manufacturing facility.
Korean Translation
2026년 3월 20일 미국 록빌 생산 시설 인수 자금 조달을 위해 100% 자회사인 미국 법인에 5,200억 원 규모의 유상증자를 결정했다고 공시함.
Related Recent Events
Samsung Biologics Co Ltd (207940) · Earnings Release
Q1 2026 earnings release is scheduled for April 29, 2026; low impact from routine disclosure expected.
4/29/2026, 12:00:00 AM
Samsung Electronics Co Ltd (005930) · Earnings Release
Analysts forecast the company will announce strong Q1 2026 earnings on April 28, 2026, with operating profit estimates around KRW 38 trillion, driven by continued strength in the semiconductor market, forecasted.
4/28/2026, 12:00:00 AM
Posco Future M Co Ltd (003670) · Earnings Release
Q1 2026 earnings release scheduled. This event is estimated to have a medium price impact of over 5%.
4/23/2026, 12:00:00 AM
Celltrion Inc (068270) · Other
The company will cancel 9.11 million treasury shares (approx. 4% of total shares) on 2026-04-01 as decided at the annual general meeting on 2026-03-24, expected.
4/1/2026, 12:00:00 AM
COWAY Co Ltd (021240) · Other
The Annual General Meeting is scheduled for March 31, 2026, amid a conflict with activist fund Align Partners over board composition and governance, leading both parties to request court-appointed inspectors for the meeting; high impact expected due to potential management changes scheduled.
3/31/2026, 12:00:00 AM
Isupetasys Co Ltd (007660) · Other
The 54th annual general meeting of shareholders is scheduled to be held on 2026-03-31. Agenda items include reporting on the approved FY2025 financial statements and the appointment of directors; the routine nature justifies a Low importance scheduled.
3/31/2026, 12:00:00 AM